Cargando…
COVID-19-associated liver injury: from bedside to bench
The outbreak of coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has been a global challenge since December 2019. Although most patients with COVID-19 exhibit mild clinical manifestations, in approximately 5% of these patients, the disease...
Autores principales: | Li, Dongxiao, Ding, Xiangming, Xie, Meng, Tian, Dean, Xia, Limin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Singapore
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7849620/ https://www.ncbi.nlm.nih.gov/pubmed/33527211 http://dx.doi.org/10.1007/s00535-021-01760-9 |
Ejemplares similares
-
Reply to: “COVID-19-associated liver injury (COVALI): role of hepatologists”
por: Li, Dongxiao, et al.
Publicado: (2021) -
Organoids of liver diseases: From bench to bedside
por: Wu, Li-Jun, et al.
Publicado: (2019) -
Takotsubo Syndrome: From Bench to Bedside and Bedside to Bench
por: Pelliccia, Francesco, et al.
Publicado: (2022) -
COVID-19 and thrombosis: From bench to bedside
por: Ali, Mohammad A.M., et al.
Publicado: (2021) -
From bench to bedside
por: Verdant, Colin L
Publicado: (2012)